Maverick Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

Maverick Capital’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,854,488	Closed	-$73.7M	–	207
2026 Q1	$73.7M	Buy	1,854,488 +210,764	+13%	+$5.39M	0.85%	38
2025 Q4	$41.1M	Buy	+1,643,724	New	+$41.6M	0.44%	46

Maverick Capital's CNTA Position: Q2 2026 in Review

Maverick Capital sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 1,854,488 shares — an estimated $73.7M sold.

Maverick Capital first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $73.7M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Maverick Capital reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Maverick Capital sold 1,854,488 Centessa Pharmaceuticals shares in Q2 2026, an estimated $73.7M.
Maverick Capital first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Maverick Capital's Centessa Pharmaceuticals position peaked at $73.7M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.